Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Nuvation Bio (NUVB) EBIT Margin (2024 - 2025)

Historic EBIT Margin for Nuvation Bio (NUVB) over the last 2 years, with Q3 2025 value amounting to 430.14%.

  • Nuvation Bio's EBIT Margin rose 61862300.0% to 430.14% in Q3 2025 from the same period last year, while for Sep 2025 it was 870.98%, marking a year-over-year increase of 250085800.0%. This contributed to the annual value of 7527.33% for FY2024, which is N/A changed from last year.
  • According to the latest figures from Q3 2025, Nuvation Bio's EBIT Margin is 430.14%, which was up 61862300.0% from 1315.73% recorded in Q2 2025.
  • In the past 5 years, Nuvation Bio's EBIT Margin ranged from a high of 430.14% in Q3 2025 and a low of 32779.44% during Q2 2024